Sameer Gupta, M.D., M.P.H. | Hematology/Oncology

Specialties

Medical Oncology
Board Certified in 2011

Hematology
Board Certified in 2011

Internal Medicine
Board Certified in 2011

Location

Bryn Mawr Medical Arts Pavilion
825 Old Lancaster Road
Suite 440
Bryn Mawr, PA 19010

Fax: (610) 525-8561

Education & Training

Medical School
Maulana Azad Medical College, New Delhi, India

Masters
University of Alabama at Birmingham

Residency
State University of New York at Buffalo
All India Institute of Medical Sciences, New Delhi, India

Fellowships
Fox Chase Cancer Center
Temple University Hospital

Affiliations

Bryn Mawr Hospital

Lankenau Hospital

Paoli Hospital

Clinical/Dept Titles

Clinical Assistant Professor
Jefferson Medical College

Attending Physician, Hematology-Oncology
Bryn Mawr Hospital

Patient Stories

Professional Advisory Boards

Current Memberships & Activities

American Association for Cancer Research

American Society of Clinical Oncology

American Society of Hematology

Honors & Awards

Philadelphia magazine Top Doctors™ 2019
Medical Oncology – Sameer Gupta, M.D., M.P.H.

Philadelphia magazine Top Doctors™ 2018
Medical Oncology – Sameer Gupta, M.D., M.P.H.

Philadelphia magazine Top Doctors™ 2017
Medical Oncology – Sameer Gupta, M.D., M.P.H.

2013-2019, Top Doctor, Main Line Today; Hematology and Oncology

2010 ASCO/AACR Methods in Clinical Cancer Research Workshop. Selected Participant.

2010 Cancer Education Consortium Molecular and Translational Oncology Workshop. Selected Participant.

2009 Cancer Education Consortium Pharmacology of Anticancer Agents Workshop. Selected Participant.

2009 Sanofi-Aventis Fellows Travel Grant Recipient, American Society of Hematology Annual Meeting

2009 Fellows Recognition Program, National Comprehensive Cancer Network Annual Meeting

2008 Dexter S. Levy House Staff Award for Excellence in Bedside Teaching, Internal Medicine Program, State University of New York at Buffalo

2006 Norman Chassin Award for Best Intern, Internal Medicine Program, State University of New York at Buffalo

2005 Academic Excellence Award, International Scholars and Student Services, University of Alabama at Birmingham

2005 Academic Excellence Recognition, School of Public Health, University of Alabama at Birmingham

Recent Clinical Studies Published

Ali SA, Gupta S, Sehgal R, Vogel V. Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J. 2012 Mar;18(2):139-44.(PMID: 22356297)

Gupta S, Engstrom PF and Cohen SJ. Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors: Invited Review, Clinical Colorectal Cancer, August 1, 2011. (PMID: 21813338)

Gupta S and Goldstein L. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735. Invited Commentary, Breast Diseases: A Year Book Quarterly. Vol. 21 No. 3, October 2010

Aggarwal C, Gupta S, Hahn T et al. Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies. Leukemia and Lymphoma, 2008 Aug; 49(8):1494-500. (PMID: 18766961)

Gupta S, Almyroudis N, Battiwala M et al. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease, 2007 Jun; 9(2):156-60. (PMID: 17462004)

Gupta S, Silliman C and Trump DL. Docetaxel Induced Meibomian Duct Inflammation and Blockage Leading to Chalazion Formation. Prostate Cancer and Prostatic Diseases, 2007; 10: 396-397. (PMID: 17404582)

Aggarwal C and Gupta S. Case 24-2006: A Woman with Hypotension after an Overdose of Amlodipine. New England Journal of Medicine, 2006: 355; 1936; author reply 1937-8. (PMID: 17079775)

Aggarwal C, Gupta S, Vaughan WP et al. Improved Outcomes in Intermediate and High Risk Aggressive Non-Hodgkin’s Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide and Etoposide Preparative Regimen. Biology of Blood and Marrow Transplantation, 2006, 12:770-777. (PMID: 16785066)

Gupta R and Gupta S. Urticaria due to inhalant allergens. Indian J Dermatol Venereol Leprol 2003; 69:429. (PMID: 17642963)

Gupta R and Gupta S. Fever due to levamisole. Indian J Dermatol Venereol Leprol 2003; 69:237-238. (PMID: 17642899)

Are you ready for our Jumpstart© with OPTIFAST® Program?

Let’s get started! Answer a few basic questions to see if Jumpstart© with OPTIFAST® Program is right for you.

We commit our TIME to you. Can you...commit to once weekly attendance in the evenings?
We commit ACCOUNTABILITY for your needs.Can you...commit to daily written tracking of nutrition and activity?
We commit ENCOURAGEMENT for your goal.Can you...commit to beginning planned physical activity?
Name